MetaVia Inc. (MTVA)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.43
- As of
Kresmion compiles this page from MTVA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
MetaVia Inc. (MTVA): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-05.
See the full MTVA dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for MTVA on one page. Preview it with sample data, then open it live with a free account.
Preview the MTVA dossierActive events for MTVA
- mediumEarnings below estimates
Q2-2026: Missed consensus by 7.6%, EPS $-0.90 vs $-0.8364 estimate
- high13F: large increase
CITADEL ADVISORS LLC added +402% to MTVA (2026Q2)
- mediumEarnings above estimates
Q2-2025: Beat consensus by 17.8% - EPS $-2.86 vs $-3.4782 estimate
- mediumEarnings above estimates
Q3-2025: Beat consensus by 38.2% - EPS $-1.54 vs $-2.4908 estimate
- mediumEarnings above estimates
Q4-2025: Beat consensus by 66.9% - EPS $-0.42 vs $-1.2674 estimate
FREE, NO ACCOUNT
Every event on MTVA, as it fires
New filings, 13F moves and cross asset events on MTVA land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
MTVA positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| CITADEL ADVISORS LLC FundCUSIP 64132R503 · 2026Q2 | $88K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, MTVA
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
MTVA's 10-Q filed Aug 6, 2026 states:
These conditions raise substantial doubt about our ability to continue as a going concern within one year from the issuance of these condensed consolidated financial statements.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on MTVA
MTVA against its peers
MTVA's return on equity of -243.3% ranks in the 26th percentile of 20 Biotechnology sub-industry peers, fiscal periods ending between 2025-03-31 and 2026-06-30.
| Metric | MTVA | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 942962 | n/a | 8 |
| Gross margin | n/a | 80.5% | n/a | 5 |
| Operating margin | n/a | -1334.8% | n/a | 8 |
| Net margin | n/a | -1227.1% | n/a | 9 |
| Return on equity | -243.3% | -114.2% | 26 | 20 |
Peers (23): LEXX, CALC, PHIO, CURX, GTBP, INTS, BCLI, RKTO, ICU, INAB, GDTC, BLRX, LTRN, CMMB, ENSC, HIND, LSTA, PTN, ANEB, PBM, ASBP, TOVX, BIVI. Left out: SPRC (period gap), MBRX (no annual filing). Fiscal periods ending between 2025-03-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (MTVA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in MTVA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on MTVA in the last 180 days.
Upstream: SEC EDGAR filings for MTVA
Kresmion, "MetaVia Inc. (MTVA) institutional holdings and SEC filings", data as of 2026-11-05, https://kresmion.com/research/MTVA. Upstream data: SEC EDGAR filings for MTVA.
Link to this data (HTML):
<a href="https://kresmion.com/research/MTVA">MetaVia Inc. (MTVA) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow MTVA on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to MTVA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.